Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve

Coronary; Ischemic Clinical Trial

— RFR  

Official title:

Derivation and Validation of a Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03461705
• Other study ID #: AAAR4732
• Status: Terminated
• Phase: N/A
• Start date: October 20, 2017
• Est. completion date: August 2, 2018

Study information

• Verified date: January 2020
• Source: Columbia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will enroll patients who are referred for coronary angiography and require physiological assessment to see if the lesion can be treated as per the local standard of care. Approximately 92 participants will be enrolled. There are no follow up visits required so participation in this study will end when subjects are discharged from the hospital.The study will be comparing the resting flow reserve against the instantaneous wave-free ratio (iFR) and fractional flow reserve. All these tests offer a way to image a legion and determine if it is suitable to be treated. FFR measures the pressure differences across (narrowed coronary arteries usually due to atherosclerosis), iFR's are performed during cardiac catheterisation (angiography) using invasive coronary pressure wires which are placed in the arteries of the heart that are to be assessed and the Resting flow reserve looks at the maximum increase in blood flow through the coronary arteries above the normal resting volume.

Description:

Fractional flow reserve (FFR) measurement by under hyperemic conditions has become the invasive gold standard for determining the physiologic extent of cardiac ischemia, and which has been validated in several clinical outcomes studies as a way of optimizing case selection for percutaneous coronary intervention (PCI). More recently in two large-scale randomized controlled trials using a non-hyperemic resting measurement, the instantaneous wave free ratio (iFR) showed non-inferiority in major adverse cardiovascular events (MACE) comparing iFR to FFR for physiological assessment of moderate coronary stenosis. FFR is calculated as the ratio of the distal coronary pressure to the aortic pressure (Pd/Pa) during maximal micro-circulatory relaxation. iFR is a diagnostic tool used to assess whether a stenosis is causing a limitation of blood flow in coronary arteries with subsequent ischemia. iFR is performed during cardiac catheterization (angiography) using invasive coronary pressure wires which are placed in the coronary arteries that are to be assessed. The iFR negates the time averaging and administration of vasodilators necessary for FFR by identifying from the resting pressure waveform a period when the native microcirculatory resistance is constant and minimized in diastole. The study is looking at the accuracy and precision of a novel adenosine-independent index of coronary artery stenosis, the resting flow reserve, against the instantaneous wave-free ratio and fractional flow reserve.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 5
• Est. completion date: August 2, 2018
• Est. primary completion date: August 2, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Age = 18 years.

2. Patient provides signed written informed consent before any study-specific procedure.

3. Undergoing coronary angiography, for silent ischemia, stable angina, acute coronary syndrome, or other acceptable indication per the local standard of care.

4. Angiographically 40%-90% stenosis present in at least one native coronary artery.

5. Undergoing physiological assessment for standard clinical or diagnostic indications

Exclusion Criteria:

1. Aorto-ostial lesion location within 3 mm of the aorta junction (both right and left).

2. Left main stenosis

3. Vessel(s) and lesion(s) not amenable for percutaneous coronary intervention (PCI) , for example diffuse disease.

4. Saphenous vein graft, chronic total occlusion

5. Haemodynamic instability at the time of intervention (heart rate<50 beats per minute, systolic blood pressure <90mmHg), balloon pump

6. Currently participating in another clinical study that interferes with study results.

7. Pregnant or nursing subjects and those who plan pregnancy in the period up to 1 year following index procedure.

8. Any other medical condition that in the opinion of the investigator will interfere with patient safety or study results.

9. High degree A-V block, sinus node disease.

10. Asthma/Chronic obstructive pulmonary disease (COPD) with active wheeze

11. Known hypersensitivity to adenosine

12. ST-Elevation Myocardial Infarction (STEMI) within 48 hours.

Related Conditions & MeSH terms

• Constriction, Pathologic
• Coronary Stenosis
• Coronary; Ischemic

Intervention

Device:
• Volcano Verrata Pressure Wire
Steerable guidewire with a pressure transducer mounted 3cm proximal to the tip. The guidewire has a diameter of 0.014". and is packaged preconnected to the connector with a torque device to facilitate navigation through the vasculature.
• St. Jude Medical (SJM) Aeris Pressure Wire System
The pressure wire is a 0.014'' guidewire with a pressure and temperature sensor integrated into the tip to enable measurements of physiological parameters.

Locations

Country	Name	City	State
United States	Columbia University	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage Agreement Between Mean RFR and iFR Measurements	Mean RFR measurements will be compared against mean iFR measurements to determine if there is an agreement between RFR and iFR for detection of ischemia.	During procedure
Secondary	Lesion Classification (FFR=/>0.80) by RFR		During procedure
Secondary	Lesion Classification (FFR=/>0.80) by iFR		During procedure
Secondary	Pressure Drift of RFR		During procedure
Secondary	Pressure Drift of iFR		During procedure
Secondary	Measurement Reproducibility for RFR	Reproducibility of RFR will be tested against iFR. Reproducibility will be measured by comparing the measure of RFR (minimal ratio of distal coronary pressure/aortic pressure) at time point 1 versus time point 2 against iFR (minimal ratio of distal coronary pressure/aortic pressure during the wave-free period of diastole) at time point 1 versus time point 2.	During procedure
Secondary	Measurement Reproducibility for iFR	Reproducibility of iFR will be tested against RFR. Reproducibility will be measured by comparing the measure of iFR (minimal ratio of distal coronary pressure/aortic pressure during the wave-free period of diastole) at time point 1 versus time point 2 against RFR (minimal ratio of distal coronary pressure/aortic pressure) at time point 1 versus time point 2.	During procedure
Secondary	Ability to Advance to the Target Lesion and Measure RFR and iFR	Percentage of technical failure due to the inability to deliver the wire and measure out of total number of all procedures	During procedure